Fulcrum Therapeutics, Inc.
NASDAQ:FULCBiotechnology
Healthcare
$3.72 +1.71%
+$0.06 today
- Market cap
- $284.14M
- Beta
- 2.92
- P/E (TTM)
- -3.6
- EPS (TTM)
- -$1.00
52W Low $2.83High $15.74
Volume 0.63M
Average 1.78M
Price history
Fulcrum Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-61.77%
Period high
$14.60
Period low
$3.14
Latest
$3.72
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 425 | Nov 12, 2026 | Nov 12, 2026 | |
| 424B3 | Nov 4, 2026 | Nov 4, 2026 | |
| EFFECT | Nov 4, 2026 | Nov 5, 2026 | |
| S-4/A | Nov 3, 2026 | Nov 3, 2026 | |
| SC 13G/A | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| S-4/A | Oct 20, 2026 | Oct 20, 2026 | |
| S-4/A | Oct 8, 2026 | Oct 8, 2026 | |
| S-4 | Sep 2, 2026 | Sep 1, 2026 | |
| 425 | Aug 17, 2026 | Aug 17, 2026 | |
| 425 | Aug 17, 2026 | Aug 17, 2026 |
Competitors
Who does Fulcrum Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about FULC's filings, answered from its disclosures.
What is the latest FULC filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does FULC have?
Intrinsic Alpha currently shows 20 recent filings for FULC.
Continue the stock analysis
Jump to another research area for this company.